Grown Rogue International (GRUSF) Treasury Shares (2018)
Grown Rogue International's (GRUSF) quarterly Treasury Shares came in at $916511.8 in Q3 2018.
Grown Rogue International (GRUSF) Treasury Shares (2018) Analysis & Trends
Grown Rogue International's Treasury Shares history runs 1 years deep, the most recent figure standing at $916511.8 for Q3 2018.
- On a quarterly basis, Treasury Shares changed N/A year-over-year to $916511.8 in Q3 2018; TTM through Aug 2018 was $916511.8, a N/A change from a year earlier, with the FY2018 full-year figure at $916511.8, changed N/A from the prior year.
- Treasury Shares was little changed at $916511.8 in Q3 2018 per GRUSF's latest filing.
- Across five years, Treasury Shares topped out at $916511.8 in Q3 2018 and bottomed at $916511.8 in Q3 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 62.52 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 107.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.29 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 313.27 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.44 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2018 | 916,511.80 |
| Aug 31, 2018 | 916,511.80 |